Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.75
+1.100.44%
Volume:204.54K
Turnover:51.63M
Market Cap:570.33M
PE:- -
High:259.01
Open:256.20
Low:247.14
Close:249.65
52wk High:341.93
52wk Low:95.98
Shares:2.27M
Float Shares:2.27M
Volume Ratio:1.72
T/O Rate:8.99%
Dividend:0.90
Dividend Rate:0.36%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

EPF Raises Stake in IHH Healthcare to 13.2%

TIPRANKS
·
Sep 22

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

GlobeNewswire
·
Sep 22

Observe Medical Launches New Website to Deepen Dialogue With Healthcare Decision-Makers

TIPRANKS
·
Sep 22

Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)

TIPRANKS
·
Sep 22

Health Care Roundup: Market Talk

Dow Jones
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)

TIPRANKS
·
Sep 22

FDA Places Sheng Nuo Biotec Subsidiary on Import Alert List 66-40

Stock News
·
Sep 22

Under the Radar: Grail Shares Surge on FDA Results

Dow Jones
·
Sep 22

Health Care up on Drug Breakthrough Hopes - Health Care Roundup

Dow Jones
·
Sep 22

Health Care Roundup: Market Talk

Dow Jones
·
Sep 22

Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Sep 22

Sector Update: Healthcare

MT Newswires Live
·
Sep 22

Update: Amneal Pharmaceuticals Shares Rise After FDA Approval for Lanreotide Injection

MT Newswires Live
·
Sep 22

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 22

Valneva (VALN) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Sep 22

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Sep 22

Health Care Roundup: Market Talk

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Lipocine (LPCN)

TIPRANKS
·
Sep 22

FDA Platform Designation Strengthens AdenoVerse Outlook; Analyst Maintains Buy Rating and $18 Price Target on Precigen

TIPRANKS
·
Sep 21

Grail Stock Soars 33% Ahead of Multi-Cancer Blood Test Review from FDA

Dow Jones
·
Sep 21